Literature DB >> 27096287

The Role of Melatonin in Palliative Care #306.

Georgina Waldman, Jennifer Pruskowski, Robert Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27096287      PMCID： PMC4860671          DOI： 10.1089/jpm.2016.0023

Source DB:  PubMed          Journal:  J Palliat Med        ISSN： 1557-7740            Impact factor:   2.947


× No keyword cloud information.
  13 in total

Review 1.  The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.

Authors:  Ye-min Wang; Bao-zhe Jin; Fang Ai; Chang-hong Duan; Yi-zhong Lu; Ting-fang Dong; Qing-lin Fu
Journal:  Cancer Chemother Pharmacol       Date:  2012-01-24       Impact factor: 3.333

2.  Variable bioavailability of oral melatonin.

Authors:  W L Di; A Kadva; A Johnston; R Silman
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

Review 3.  The therapeutic application of melatonin in supportive care and palliative medicine.

Authors:  Fade Mahmoud; Nabeel Sarhill; Miroslaw A Mazurczak
Journal:  Am J Hosp Palliat Care       Date:  2005 Jul-Aug       Impact factor: 2.500

4.  Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial.

Authors:  Tareef Al-Aama; Christopher Brymer; Iris Gutmanis; Sarah M Woolmore-Goodwin; Jacquelin Esbaugh; Monidipa Dasgupta
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-15       Impact factor: 3.485

5.  Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Aumkhae Sookprasert; Nutjaree Pratheepawanit Johns; Anakapong Phunmanee; Parichart Pongthai; Areewan Cheawchanwattana; Jeff Johns; Julraht Konsil; Preeyaporn Plaimee; Supatra Porasuphatana; Suthiphan Jitpimolmard
Journal:  Anticancer Res       Date:  2014-12       Impact factor: 2.480

6.  Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.

Authors:  Kotaro Hatta; Yasuhiro Kishi; Ken Wada; Takashi Takeuchi; Toshinari Odawara; Chie Usui; Hiroyuki Nakamura
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

Review 7.  Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation.

Authors:  James E Fildes; Nizar Yonan; Brian G Keevil
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

Review 8.  Pharmacotherapies for sleep disturbances in Alzheimer's disease.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2014-03-21

9.  Stimulation of C14-melatonin synthesis from C14-tryptophan by noradrenaline in rat pineal in organ culture.

Authors:  J Axelrod; H M Shein; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

10.  Clinical uses of melatonin in pediatrics.

Authors:  Emilio J Sánchez-Barceló; Maria D Mediavilla; Russel J Reiter
Journal:  Int J Pediatr       Date:  2011-06-16
View more
  3 in total

Review 1.  Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.

Authors:  Wamidh H Talib; Ahmad Riyad Alsayed; Alaa Abuawad; Safa Daoud; Asma Ismail Mahmod
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

Review 2.  Promising Antineoplastic Actions of Melatonin.

Authors:  Gaia Favero; Enrico Moretti; Francesca Bonomini; Russel J Reiter; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Front Pharmacol       Date:  2018-10-16       Impact factor: 5.810

Review 3.  Melatonin: an anti-tumor agent for osteosarcoma.

Authors:  Hadis Fathizadeh; Hamed Mirzaei; Zatollah Asemi
Journal:  Cancer Cell Int       Date:  2019-11-29       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.